— Know what they know.
Not Investment Advice

ACUTAAS.NS NSE

Acutaas Chemicals Ltd.
1W: -2.7% 1M: +0.7% 3M: -13.5% YTD: +55.9% 1Y: +143.0%
₹3,200.00 ($33.23)
-79.40 (-2.42%)
 
NSE · Basic Materials · Chemicals - Specialty · Tech Score Neutral · Power 48 · ₹262.0B mcap · 48M float · 0.774% daily turnover
Smart Money Score
Watch 25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap₹262.0B ($2.7B)
52W Range1040.5-3740
Volume381,484
Avg Volume373,252
Beta-0.01
Dividend₹2.50
Analyst Ratings
No analyst coverage
Company Info
CEONareshkumar Ramjibhai Patel
Employees1,007
SectorBasic Materials
IndustryChemicals - Specialty
IPO Date2021-09-14
Plot No. 440/4, 5 & 6
Surat, GU 394230
IN
91 72 2797 7744
About Acutaas Chemicals Ltd.

Based in Surat, India, Acutaas Chemicals Limited, founded in 2004, is engaged in the development, production, and global distribution of pharmaceutical intermediates. These crucial compounds are utilized in both regulated and generic active pharmaceutical ingredients (APIs) for a wide range of medical treatments, including those for anti-retroviral applications, inflammation, psychiatric conditions, cancer, Parkinson's disease, depression, and blood coagulation disorders. The company also produces a diverse portfolio of specialty chemicals, serving various industries such as battery manufacturing, personal care, agricultural chemicals, protective coatings, electronics, and general industrial processes. Notable offerings in this category include photoresist chemicals for semiconductor fabrication and electrolyte additives essential for lithium battery cells. Additionally, Acutaas Chemicals provides commodity chemicals like parabens and methyl salicylate, among other fine chemicals, which find application in cosmetics, agricultural products, and various chemical sectors. The company was previously known as Ami Organics Limited, changing its name to Acutaas Chemicals Limited in May 2025.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms